5/16/2019 8:08:23 AM
AstraZeneca To Present New Research Across Oncology Portfolio At ASCO Meeting
5/10/2019 2:07:01 AM
AstraZeneca Reports Pooled Analyses Of Roxadustat Global Phase III Programme Confirmed Cardiovascular Safety
5/8/2019 2:09:13 AM
AstraZeneca And Daiichi Sankyo Report Positive Top-line Results For Pivotal Phase II DESTINY-Breast01 Trial Of DS-8201
5/7/2019 2:22:51 AM
AstraZeneca Says Calquence PhIII ASCEND Trial Met Primary Endpoint
4/29/2019 2:05:27 AM
AstraZeneca: Lynparza Gets Positive EU CHMP Opinion
4/26/2019 2:03:53 AM
AstraZeneca Posts Q1 Core EPS Of $0.89; Reported EPS $0.47
4/10/2019 2:05:10 AM
AstraZeneca Says Lynparza Approved In EU For Germline BRCA1/2-mutations
4/4/2019 7:09:37 AM
Myriad, AstraZeneca And Merck Expand Companion Diagnostic Partnership
4/1/2019 2:06:09 AM
AstraZeneca Says Selumetinib Gets Breakthrough Therapy Designation
3/29/2019 3:28:18 AM
AstraZeneca Plans To Raise Up To About $3.5 Bln Through Placing Of New Shares
3/29/2019 12:22:28 AM
Daiichi Sankyo, AstraZeneca Sign Cancer Drug Deal; Announces CEO Change